- £172.60m
- £166.59m
- £38.44m
Board Change Update
Issue of Share Options/PDMR Shareholdings
Diaceutics Announces Key Leadership Appointment
Holding(s) in Company
PDMR Shareholding/Share Incentive Plan
Brief: Diaceutics Says Jordan Clark Joins As Executive Director
Board Changes
Brief: Diaceutics H1 pretax profit GBP -3.3 million
Brief: Diaceutics HY Loss Before Tax 3.3 Mln Stg
H1 2024 Results - Continued Performance & Growth
Notice of Results & Presentations
PDMR Shareholding/Share Incentive Plan
PDMR Shareholding/SIP and TVR
Issue of Share Options/PDMR Shareholdings
Brief: Diaceutics Grows Revenues By 24% In H1
Brief: Diaceutics Says Deborah Davis, Non-Executive Chair To Step Down
Board Changes
Revenue growth of 24% in H1 with 55% now recurring
Senior Management Appointments